Adjuvant therapy of resected non-small-cell lung cancer

Curr Opin Oncol. 2000 Mar;12(2):149-55. doi: 10.1097/00001622-200003000-00009.

Abstract

The administration of adjuvant therapy after complete resection of non-small-cell lung cancer is controversial. Radiation therapy and chemotherapy have been used individually and concomitantly in efforts to prevent local recurrence and improve survival. However, recent phase II and III trials and a meta-analysis have produced conflicting results. Postoperative adjuvant therapy remains a subject of active investigation.

Publication types

  • Review

MeSH terms

  • Chemotherapy, Adjuvant
  • Clinical Trials as Topic
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / radiotherapy*
  • Lung Neoplasms / surgery
  • Patient Care Planning
  • Prognosis
  • Radiotherapy, Adjuvant